NASDAQ · ASTH
Healthcare · Medical - Care Facilities
$37.55
Up+$0.85 (+2.26%)
Updated Oct 12, 2026, 11:57 PM
SID Score
5.1/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · ASTH
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
ASTH closed at $37.55 after 20 trading sessions, down 5.18% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $35.87 | $37.70 | $35.87 | $37.55 | 317.05K |
| Oct 8, 2026 | $36.81 | $36.96 | $35.38 | $35.87 | 351.05K |
| Oct 7, 2026 | $36.65 | $37.66 | $36.65 | $37.14 | 664.51K |
| Oct 6, 2026 | $37.115 | $37.70 | $36.78 | $37.00 | 227.13K |
| Oct 5, 2026 | $35.73 | $37.06 | $35.73 | $36.81 | 389.92K |
| Oct 2, 2026 | $35.53 | $36.39 | $35.11 | $35.88 | 310.36K |
| Oct 1, 2026 | $35.61 | $35.68 | $34.71 | $34.91 | 266.86K |
| Sep 30, 2026 | $35.49 | $35.97 | $34.81 | $35.57 | 400.58K |
| Sep 29, 2026 | $35.09 | $35.66 | $34.46 | $35.45 | 264.26K |
| Sep 28, 2026 | $36.29 | $36.83 | $34.735 | $35.13 | 363.55K |
| Sep 25, 2026 | $34.46 | $36.41 | $34.11 | $36.37 | 336.61K |
| Sep 24, 2026 | $34.32 | $34.535 | $33.54 | $34.44 | 391.47K |
| Sep 23, 2026 | $33.08 | $34.46 | $32.22 | $34.34 | 405.13K |
| Sep 22, 2026 | $34.11 | $35.515 | $33.395 | $35.11 | 409.5K |
| Sep 21, 2026 | $34.40 | $34.44 | $32.22 | $33.55 | 603.5K |
| Sep 18, 2026 | $33.87 | $35.215 | $33.1401 | $34.36 | 1.44M |
| Sep 17, 2026 | $37.96 | $38.1605 | $34.17 | $34.30 | 1.05M |
| Sep 16, 2026 | $38.35 | $39.52 | $37.60 | $37.70 | 263.46K |
| Sep 15, 2026 | $39.70 | $39.70 | $38.00 | $38.35 | 314.33K |
| Sep 14, 2026 | $38.21 | $39.95 | $38.21 | $39.60 | 321.27K |
The latest Smart Investors Daily articles mentioning ASTH.
Company
Market Activity
Research & News
ASTH research
Company profile and research snapshot.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 1, 2026 | Freedom Capital Markets | Buy | — |
| Sep 15, 2026 | Oppenheimer | Outperform | — |
| Aug 11, 2026 | Truist Securities | Buy | — |
| Aug 7, 2026 | Barclays | Overweight | — |
| Jul 14, 2026 | TD Cowen | Buy | — |
No generated briefing is available yet.
Yahoo · Sep 30, 2026
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) and its peers.
Yahoo · Sep 23, 2026
Shares of healthcare services company Astrana Health fell 5.5% in the afternoon session after the company disclosed a "material" cybersecurity incident and data breach at its subsidiary, Astrana Health Management.
Benzinga · Sep 23, 2026
Astrana Health (NASDAQ:ASTH) affirms FY2026 sales outlook from $3.800 billion-$4.100 billion to $3.800 billion-$4.100 billion vs $4.004 billion estimate.
Benzinga · Sep 23, 2026
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001083446/000110465926109813/asth-20260922x8k.htm
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ASTH.
